Cantor Fitzgerlad

'Sea Change': Irwin Naturals, Numinus And Field Trip Discuss Psychedelics At Cantor Webinar

Sit Tight And Hang On To Your Cannabis Stocks, Analyst Talks Momentum & Who Will Come Out On Top

Ayr Wellness: Analyst Reduces Price Target And Stays Neutral After Q3 Results

Sit Tight And Hang On To Your Cannabis Stocks, Analyst Talks Momentum & Who Will Come Out On Top

Ayr Wellness: Analyst Reduces Price Target And Stays Neutral After Q3 Results

Canopy Growth: Analyst Maintains Price Target Of $3.30, Stays Neutral After Q3 Results

Acreage Holdings: Analyst Increases Price Target To $1.44 And Remains Neutral

Canopy Growth: Analyst Maintains Price Target Of $3.30, Stays Neutral After Q3 Results

Acreage Holdings: Analyst Increases Price Target To $1.44 And Remains Neutral

WM Technology: Analyst Lowers Price Target To $5.00 But Stays Overweight

What Happens To Cannabis Bills If Republicans Take House And Senate? Here's One View

Cantor Fitzgerlad Recent News

Jushi Holdings Will Soon Announce 3Q, Analyst Puts Price Target At $2.25 And Maintains Neutral Rating

Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF) will announce its financial results for the third quarter before the market opens on Monday, November 14, 2022.

Green Thumb Industries Among Top Cannabis MSO Stocks Ahead Of Earnings Season, Analyst Tells Us Why

As earnings season approaches, Cantor Fitzgerald analyst Pablo Zuanic discussed his expectations. One of his top stock picks, Green Thumb Industries Inc.

Is Aurora Cannabis' 'Business Transformation Plan' Yielding Results?

Aurora Cannabis (NASDAQ: ACB) (TSX: ACB) reported a 45% year-over-year plunge in consumer cannabis net revenue, while its total net revenue in the fourth quarte

Cantor Remains Neutral On Aleafia Health, Lowers Price Target On Sectoral Derating, Sees Value

Canadian cannabis company Aleafia Health (OTCQF: ALEAF) recently disclosed its first-quarter financial results with net revenue of CA$7.06 milli

Aphria One Step Closer To Merging With Tilray, Shareholders Overwhelmingly Approve The Deal

Aphria Inc. (TSX: APHA) (NASDAQ: APHA) confirmed Thursday it has satisfied one of the requirements for its merger with Tilray Inc. (NASDAQ: TLRY), after its shareholders approved the arrangement at a special meeting.

Cantor Analyst Raises Aphria And Tilray Price Targets Amid Merger

Cantor Fitzgerald analyst Pablo Zuanic expressed disappointment by Aphria Inc. (TSX: APHA) (NASDAQ: APHA) quarterly results in an analyst note published Friday.

Analyst: Here Are The Latest Cannabis MSO Trends In IL, MA, NV And FL

Cantor Fitzgerald analyst Pablo Zuanic provided a financial update on the latest information about US MSOs in Illinois, Massachusetts, Nevada and Florida.

Cantor Fitzgerald Lowers GW Pharmaceuticals Price Target

What Do Zogenix Drug Study Results Mean For GW Pharmaceuticals' Epidiolex?

Clearing Up Misconceptions Surrounding Aerie Pharmaceuticals

Internet Stocks Outperformed The Market During Brexit Week

Cantor Fitzgerald Initiates The Rubicon Project With Buy Rating, $22 Target

Is Yahoo In A Win-Win-Win Situation?

Cantor Still Expects Threshold Pharma To More Than Triple, Says 2016 Will Be 'Data Rich' Year

Cantor Reiterates Buy On LinkedIn, Issues 'Clearing Up'

Cantor Downgrades Lumber Liquidators, Slashes Targets On 'Too Many' Risks

What Could Be Coming For Cisco, According To Cantor Fitzgerald

Wall Street Voices Opinion On Apple Watch

Does AOL's New Ad Platform Make It A Buy?

Oracle Primed To Leverage New Cloud Solutions, Says Cantor Fitzgerald

Apple At $180? This Analyst Thinks So

Netflix Is The 'Clear Winner' As Trend Of TV Bundling Grows Stronger

Cantor Fitzgerald Expects LinkedIn's Q4 Report To Show 'Continued Business Momentum'